Skip to main content
Lady Gaga, Actual Nurtec ODT Patient

*Per IQVIA as oral brand in class (oral CGRP receptor antagonists): number one prescribed and number one in new prescriptions, since 8/6/21. Data current as of 3/31/24.

Lady Gaga Actual Nurtec ODT patient.

More than 162,000 providers have written over 6.7 million prescriptions for Nurtec ODT

The flexibility to help meet your patients’ needs1

Only Nurtec ODT treats and helps prevent all in one1,2

Well tolerated for acute and preventive treatment1

Dedicated access, savings, and support resources through Nurtec® OneSource

Requesting samples or other tools is one short form away

Per IQVIA XPO report, accessed 5/17/24. Rankings included new prescriptions and renewals.

Approximately 300 million individuals have access 

to Nurtec ODT across all channels*

Approximately 300 million individuals have access to Nurtec ODT across all channels*

With coverage for ~95% of commercially insured lives*

Find specific formulary coverage in your area:

Auto-locate

Error: Please provide a valid ZIP code.

OR

Error: Please provide a valid NPI number.

Error: Please provide either a valid ZIP code or an NPI number.

*Per Managed Markets Insights & Technology LLC as of 6/3/24.

Ellie's migraine story

Ellie
I know if I get a migraine
attack, I can take my
Nurtec ODT to help me
get back to my normal
activities. I can hang out
with my friends and family.

Ellie W.
Actual Nurtec ODT patient.
Individual results may vary.

Patients were invited to share their experiences on Nurtec ODT. All content was accurate at the time of publication.

Greg's migraine story

greg-banner-quote-desktop.png
After years on the
battlefield and multiple concussions, migraine attacks followed me home... Nurtec ODT is the only medication that can treat and prevent migraine attacks.

Greg P.
Actual Nurtec ODT patient.
Individual results may vary.

Patients were invited to share their experiences on Nurtec ODT. All content was accurate at the time of publication.

References: 1. Nurtec ODT. Package insert. Pfizer Inc. 2. Croop R, Lipton RB, Kudrow D, et al. Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial. Lancet. 2020;397(10268): 51-60. doi:10.1016/S0140-6736(20)32544-7.

Helix Image

Welcome to nurtec‑hcp.com

This website is intended for U.S. healthcare professionals only.

Are you a healthcare professional in the U.S.?

yes no